An acceptable slow-release phosphate preparation 'Slow P'

Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.

In a double-blind cross-over study, the effects of slow release (S-R) terbutaline tablets (b.i.d. 0.25 mg/kg per day) and S-R theophylline (5.31 mg/kg morning and 10.62 mg/kg evening) were compared in eleven patients with nocturnal asthma. On day seven of each treatment period, drug serum concentrations and peak expiratory flow (PEF) were measured every 2h over a 24-h period. During daytime, te...

Slow P -point Ultrafilters

We answer a question of Blass, Di Nasso, and Forti [2, 7] by proving, assuming Continuum Hypothesis or Martin’s Axiom, that (1) there exists a P -point which is not interval-to-one and (2) there exists an interval-to-one P -point which is neither quasi-selective nor weakly Ramsey.

Slow release potassium chloride treatment.

-brain levels of HCP varied between 0-442 and 1-204 nmol[g (0-18 and 0 49 ig/g).4 So myelinopathy in case 2 was probably attributable to HCP, despite the absence of clinical signs of toxicity. The trace level in case 1 suggests that myelinopathy was unrelated to HCP, for other causes of infantile spongioform myelinopathy are known, though none has been identified in small premature infants. Nev...

preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film

buccal mucoadhesive systems among novel drug delivery systems have attracted great attention in recent years due to their ability to adhere and remain on the oral mucosa and to release their drug content gradually. buccal mucoadhesive films can improve the drug therapeutic effect by enhancement of drug absorption through oral mucosa increasing the drug bioavailability via reducing the hepatic f...

preparation and evaluation of nicotine slow release mucoadhesive film for nicotine replacement therapy